| Product Code: ETC9952752 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Precision Psychiatry Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Precision Psychiatry Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Precision Psychiatry Market - Industry Life Cycle |
3.4 United Kingdom (UK) Precision Psychiatry Market - Porter's Five Forces |
3.5 United Kingdom (UK) Precision Psychiatry Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 United Kingdom (UK) Precision Psychiatry Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.7 United Kingdom (UK) Precision Psychiatry Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.8 United Kingdom (UK) Precision Psychiatry Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 United Kingdom (UK) Precision Psychiatry Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United Kingdom (UK) Precision Psychiatry Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and acceptance of precision psychiatry as an effective treatment approach. |
4.2.2 Technological advancements in precision medicine leading to personalized treatment options in psychiatry. |
4.2.3 Growing demand for personalized healthcare solutions in the mental health sector. |
4.3 Market Restraints |
4.3.1 High costs associated with precision psychiatry treatments and services. |
4.3.2 Limited coverage and reimbursement policies for precision psychiatry interventions. |
4.3.3 Data privacy and security concerns related to the use of personal genetic and health information in precision psychiatry. |
5 United Kingdom (UK) Precision Psychiatry Market Trends |
6 United Kingdom (UK) Precision Psychiatry Market, By Types |
6.1 United Kingdom (UK) Precision Psychiatry Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Precision Psychiatry Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Precision Psychiatry Market Revenues & Volume, By Products, 2021- 2031F |
6.1.4 United Kingdom (UK) Precision Psychiatry Market Revenues & Volume, By Services, 2021- 2031F |
6.2 United Kingdom (UK) Precision Psychiatry Market, By Biomarker Type |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Precision Psychiatry Market Revenues & Volume, By Genetic Biomarker, 2021- 2031F |
6.2.3 United Kingdom (UK) Precision Psychiatry Market Revenues & Volume, By Protein Biomarker, 2021- 2031F |
6.3 United Kingdom (UK) Precision Psychiatry Market, By Sample |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Precision Psychiatry Market Revenues & Volume, By Blood-Based, 2021- 2031F |
6.3.3 United Kingdom (UK) Precision Psychiatry Market Revenues & Volume, By Non-Blood-Based, 2021- 2031F |
6.4 United Kingdom (UK) Precision Psychiatry Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Precision Psychiatry Market Revenues & Volume, By Alzheimers Disease, 2021- 2031F |
6.4.3 United Kingdom (UK) Precision Psychiatry Market Revenues & Volume, By Parkinsons Disease, 2021- 2031F |
6.4.4 United Kingdom (UK) Precision Psychiatry Market Revenues & Volume, By Autism, 2021- 2031F |
6.4.5 United Kingdom (UK) Precision Psychiatry Market Revenues & Volume, By Depression, 2021- 2031F |
6.4.6 United Kingdom (UK) Precision Psychiatry Market Revenues & Volume, By Bipolar Disease, 2021- 2031F |
6.4.7 United Kingdom (UK) Precision Psychiatry Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United Kingdom (UK) Precision Psychiatry Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Precision Psychiatry Market Revenues & Volume, By Hospitals and Diagnostic Laboratories, 2021- 2031F |
6.5.3 United Kingdom (UK) Precision Psychiatry Market Revenues & Volume, By Academic and Research Institutions, 2021- 2031F |
6.5.4 United Kingdom (UK) Precision Psychiatry Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Precision Psychiatry Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Precision Psychiatry Market Export to Major Countries |
7.2 United Kingdom (UK) Precision Psychiatry Market Imports from Major Countries |
8 United Kingdom (UK) Precision Psychiatry Market Key Performance Indicators |
8.1 Rate of adoption of precision psychiatry technologies and services by healthcare providers. |
8.2 Patient satisfaction and outcomes improvement metrics in precision psychiatry treatments. |
8.3 Number of research studies and publications on precision psychiatry advancements. |
8.4 Percentage of mental health facilities offering precision psychiatry services. |
8.5 Investment trends in precision psychiatry startups and companies. |
9 United Kingdom (UK) Precision Psychiatry Market - Opportunity Assessment |
9.1 United Kingdom (UK) Precision Psychiatry Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 United Kingdom (UK) Precision Psychiatry Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.3 United Kingdom (UK) Precision Psychiatry Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.4 United Kingdom (UK) Precision Psychiatry Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 United Kingdom (UK) Precision Psychiatry Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United Kingdom (UK) Precision Psychiatry Market - Competitive Landscape |
10.1 United Kingdom (UK) Precision Psychiatry Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Precision Psychiatry Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here